Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 12, 2014, Pages 2425-2436

  Chen, Jing ^a   Wang, Rui ^a   Zhang, Kai ^a   Chen, Long Bang ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Biomarker; Long non coding RNA; Molecular target; Non small cell lung cancer

Indexed keywords

LONG UNTRANSLATED RNA; TUMOR MARKER;

BIOLOGICAL MODEL; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG NEOPLASMS; PROGNOSIS; SIGNAL TRANSDUCTION;

BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MODELS, GENETIC; PROGNOSIS; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84911365088     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12431     Document Type: Article

References (78)

1. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007; 8: 784-96.
2. Seve P, Reiman T, Dumontet C. The role of beta III tubulin in predicting chemoresistance in non-small cell lung cancer. Lung Cancer. 2010; 67: 136-43.
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57: 43-66.
4. He L, Hannon GJ. Micrornas: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5: 522-31.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97.
6. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6: 259-69.
7. Wu W, Sun M, Zou GM, et al. MicroRNA and cancer: current status and prospective. Int J Cancer. 2007; 120: 953-60.
8. Garzon R, Fabbri M, Cimmino A, et al. MicroRNA expression and function in cancer. Trends Mol Med. 2006; 12: 580-7.
9. Hutchinson JN, Ensminger AW, Clemson CM, et al. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007; 8: 39.
10. Dunham I, Kundaje A, Aldred SF, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489: 57-74.
11. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009; 136: 629-41.
12. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012; 22: 1775-89.
13. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43: 904-14.
14. Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA. 2009; 106: 11667-72.
15. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009; 458: 223-7.
16. Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010; 142: 409-19.
17. Kino T, Hurt DE, Ichijo T, et al. Noncoding RNA Gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010; 3: ra8.
18. Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs. Cell. 2007; 129: 1311-23.
19. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464: 1071-U148.
20. Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010; 329: 689-93.
21. Zhao J, Sun BK, Erwin JA, et al. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science. 2008; 322: 750-6.
22. Nagano T, Mitchell JA, Sanz LA, et al. The air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science. 2008; 322: 1717-20.
23. Pandey RR, Mondal T, Mohammad F, et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell. 2008; 32: 232-46.
24. Feng JC, Bi CM, Clark BS, et al. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev. 2006; 20: 1470-84.
25. Clark MB, Mattick JS. Long noncoding RNAs in cell biology. Semin Cell Dev Biol. 2011; 22: 366-76.
26. He HL, Nagy R, Liyanarachchi S, et al. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res. 2009; 69: 625-31.
27. Yang Y, Li H, Hou SC, et al. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell. PLoS ONE. 2013; 8: e65309.
28. Yap KL, Li SD, Munoz-Cabello AM, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38: 662-74.
29. Yu WQ, Gius D, Onyango P, et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature. 2008; 451: 202-U10.
30. Luo M, Li ZW, Wang W, et al. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 2013; 280: 1709-16.
31. He XY, Bao W, Li XC, et al. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis. Int J Mol Med. 2014; 33: 325-32.
32. Panzitt K, Tschernatsch MMO, Guelly C, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007; 132: 330-42.
33. Xie H, Ma HW, Zhou DQ. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013; 2013: 136106.
34. Pasic I, Shlien A, Durbin AD, et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res. 2010; 70: 160-71.
35. Yang F, Huo XS, Yuan SX, et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell. 2013; 49: 1083-96.
36. Gao LY, Mai A, Li X, et al. LncRNA-DQ786227-mediated cell malignant transformation induced by benzo(a)pyrene. Toxicol Lett. 2013; 223: 205-10.
37. Schmidt LH, Spieker T, Koschmieder S, et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol. 2011; 6: 1984-92.
38. Lai MC, Yang Z, Zhou L, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012; 29: 1810-6.
39. Weber DG, Johnen G, Casjens S, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Research Notes. 2013; 6: 518.
40. Ren SC, Liu YW, Xu WD, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013; 190: 2278-87.
41. Cheng W, Zhang ZY, Wang JD. Long noncoding RNAs: new players in prostate cancer. Cancer Lett. 2013; 339: 8-14.
42. Zhou YL, Zhang X, Klibanski A. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol. 2012; 48: R45-53.
43. Lu KH, Li W, Liu XH, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013; 13: 461.
44. Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011; 1: 391-407.
45. Northcott PA, Shih DJH, Peacock J, et al. Subgroup-specific structural variation across 1, 000 medulloblastoma genomes. Nature. 2012; 488: 49-56.
46. Khaitan D, Dinger ME, Mazar J, et al. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011; 71: 3852-62.
47. Lanz RB, Chua SS, Barron N, et al. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol. 2003; 23: 7163-76.
48. Braconi C, Valeri N, Kogure T, et al. Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci USA. 2011; 108: 786-91.
49. Wang F, Li X, Xie XJ, et al. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett. 2008; 582: 1919-27.
50. Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Front Genet. 2012; 3: 219.
51. Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in cancer diagnostics. Front Genet. 2012; 3: 32.
52. Fradet YF, Saad F, Aprikian A, et al. uPM3, a new molecular urine test for the detection of prostate cancer. Urology. 2004; 64: 311-5.
53. Ji P, Diederichs S, Wang WB, et al. MALAT-1, a novel noncoding RNA, and thymosin beta 4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003; 22: 8031-41.
54. Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013; 9: e1003368.
55. Guffanti A, Iacono M, Pelucchi P, et al. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics. 2009; 10: 163.
56. Xu CA, Yang MH, Tian J, et al. MALAT-1: a long non-coding RNA and its important 3 ' end functional motif in colorectal cancer metastasis. Int J Oncol. 2011; 39: 169-75.
57. Lin R, Maeda S, Liu C, et al. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene. 2007; 26: 851-8.
58. Ling H, Spizzo R, Atlasi Y, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013; 23: 1446-61.
59. Redis RS, Sieuwerts AM, Look MP, et al. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013; 4: 1748-62.
60. Qiu M, Xu Y, Yang X, et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol. 2014; 7: 7.
61. Hauptman N, Glavac D. Long non-coding RNA in cancer. Int J Mol Sci. 2013; 14: 4655-69.
62. Liu ZL, Sun M, Lu KH, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PLoS ONE. 2013; 8: e77293.
63. Cao W, Ribeiro RD, Liu DA, et al. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer. PLoS ONE. 2012; 7: e52984.
64. Ota T, Suzuki Y, Nishikawa T, et al. Complete sequencing and characterization of 21, 243 full-length human cDNAs. Nature Genet. 2004; 36: 40-5.
65. Teng Y, Wang XW, Wang YW, et al. Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun. 2010; 392: 373-9.
66. Tamai K, Zeng X, Liu CM, et al. A mechanism for Wnt coreceptor activation. Mol Cell. 2004; 13: 149-56.
67. Miyoshi N, Wagatsuma H, Wakana S, et al. Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells. 2000; 5: 211-20.
68. Zhang X, Zhou YL, Mehta KR, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab. 2003; 88: 5119-26.
69. Zhou Y, Zhong Y, Wang Y, et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007; 282: 24731-42.
70. Wang PJ, Ren ZQ, Sun PY. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012; 113: 1868-74.
71. Han L, Kong R, Yin DD, et al. Low expression of long noncoding RNA GAS6-AS1 predicts a poor prognosis in patients with NSCLC. Med Oncol. 2013; 30: 694.
72. Vajkoczy P, Knyazev P, Kunkel A, et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci USA. 2006; 103: 5799-804.
73. Lee Y, Lee M, Kim S. Gas6 induces cancer cell migration and epithelial-mesenchymal transition through upregulation of MAPK and Slug. Biochem Biophys Res Commun. 2013; 434: 8-14.
74. Flockhart RJ, Webster DE, Qu K, et al. BRAF (V600E) remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 2012; 22: 1006-14.
75. Sun M, Liu XH, Wang KM, et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer. 2014; 13: 68.
76. Soltermann A. Epithelial-mesenchymal transition in non-small cell lung cancer. Pathologe. 2012; 33: 311-7.
77. Kang YB, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell. 2004; 118: 277-9.
78. Zhao R, Wu Z, Zhou Q. Epithelial-mesenchymal transition and tumor metastasis. Zhongguo Fei Ai Za Zhi. 2011; 14: 620-4.